SlideShare una empresa de Scribd logo
1 de 26
Adverse Drug Reactions
dsdht.wikispaces.com
What is ADR
WHO definition : Any undesirable effect of a drug beyond its anticipated therapeutic
effects occurring during clinical use

An adverse drug reaction (ADR) is an expression that describes harm associated
with the use of given medications at a normal dosage during normal use. -

ADRs may occur following a single dose or prolonged administration of a drug or result
from the combination of two or more drugs
The meaning of this expression differs from the meaning of "side effect", as it might
also imply that the effects can be beneficial.
Why ADR is Important to know
• Over 2 Million serious ADRs yearly.
• 100,000 deaths yearly.
• ADRs 4th leading cause of death ahead of
pulmonary disease, diabetes, AIDS,
pneumonia, accidents and automobile
deaths.
• Ambulatory patients ADR rate—unknown
• Nursing home patients ADR rate— 350,000
yearly.
Institute of Medicine, National Academy Press, 2000 Lazarou J et al. JAMA
1998;279(15):1200–1205 Gurwitz JH et al. Am J Med 2000;109(2):87–94
Classification of adverse drug reaction
ABCDE Classification
Rawlins and Thompson devised a classification scheme in 1991, which continues to
be the most frequently used.

• Type A: Predictable, acute, related to mechanism of action
• Type B: Idiosyncratic, unpredictable, acute / sub-acute, not
related to known mechanism
• Type C: Chronic effects (continuous)
• Type D: Delayed effects
• Type E: End-of-treatment effects
Classification of adverse drug reaction
Type A
• Dose Related
• 80% of ADR, usually a consequence of the
drug’s primary pharmacological effect (e.g.
bleeding from warfarin, Headache with
glyceryltrinitrate (GTN))
• a low therapeutic index (e.g. nausea from
digoxin)
Classification of adverse drug reaction
Type B
• Bizarre effects (or idiosyncratic)
• dose independent and
• Unpredictable (not an extension pharmacological
action of the drug)
• For example: hepatotoxicity due to paracetamol
tinnitus induced by aspirin ototoxicity with
aminoglycosides of main
Classification of adverse drug reaction
• Type A less likely to have fatal consequences
than type B reactions
Type

Type A

Type B

Dose Relationship

Yes

No

Frequency

Common

Rarer

Mortality

Low

Higher

Morbidity

High

Lower

Treatment

Stop drug or reduce
dose

Stop drug
Classification of adverse drug reaction
Type C
• Results from Chronic or continuous use
• For example, Analgesic nephropathy
• osteoporosis during continued high-dose
glucocorticoid therapy
• tardive dyskinesia during continuous use of
antipsychotic drugs
Classification of adverse drug reaction
Type D
These reactions refer to carcinogenic and teratogenic effects.
These reactions are delayed in onset and are very rare since extensive
mutagenicity and carcinogenicity studies are done before drug is licensed.
•
•
•
•
•
•
•
•

Teratogenic Thalidomide - amelia or micromelia or phocomelia
phenytoin -fetal hydantoin syndrome
tetracyclines -teeth malformation and discoloration
aspirin -early closure of ductus arteriosus
carbamazepine -cleft lip and palate, microcephaly
wafarin - saddle nose
sodium valproate - spina bifida
DES - vaginal clear cell adenocarcinoma
Classification of adverse drug reaction
Type E
• Rebound adrenal insufficiency
• Withdrawal syndrome (tachycardia on abrupt
discontinuation of β-adrenoceptor blockade)
• Second malignancies following successful
chemotherapy.
Physiological, Pharmacological and Toxicological aspects of
metabolism of Drugs
Drug- Drug Interactions
Pharmacokinetic and pharmacodynamic
properties of one drug affect either the
pharmacokinetics or pharmacodynamics of
another drug
Pharmacokinetics:“What the body does
to the drug”
Pharmacodynamics:“What the drug does
to the body”
Types of Drug Drug Interactions
• Potentiation: Drugs with similar actions cause
an additive effect
• Coumadin and aspirin taken together cause
excessive bleeding
• Sedatives and alcohol cause excessive
sedation
Types of Drug Drug Interactions
• Interference: One drug accelerates or slows the
metabolism or excretion of another drug
Erythromycin taken with

– Digoxin = elevated blood levels of digoxin

– Coumadin = enhanced action of Coumadin
Potential for serious adverse effects!
Types of Drug Drug Interactions
• Displacement: Two drugs compete for protein
binding sites
– One drug “wins” (is bound to protein)
– Displaced drug is active in greater quantities

– Same effect as taking a higher dose of the
displaced drug!

A major cause of drug-drug interactions!
Types of Drug Drug Interactions
• Antagonism: One drug decreases the
effectiveness of another drug because of
divergent actions
– Oral ketoconazole (Nizoral) is absorbed in an
acidic environment

– H2-receptor antagonists or proton pump
inhibitors decrease acidity in the stomach
– Differing action decreases Nizoral
effectiveness
Types of Drug Drug Interactions
• CYP450 enzymes and drug-drug interactions
– CYP450 Inhibitors: Drug A inhibits CYP450 enzymes in
the liver; slows metabolism of drug B, toxic levels of
drug B accumulate
– CYP450 Inducers: Drug A stimulates production of
CYP450 enzymes; increases rate of metabolism of drug
B, clears drug B out of the system faster

A major source of drug-drug interactions!
Drug Food Interactions
• Food can alter the absorption or metabolism
of medications
• Diets can alter the bacterial flora of the
intestine and may affect the metabolism of
certain drugs
• Iron taken with acidic foods can cause
increased iron absorption
• Acetaminophen or Aspirin taken with or after
alcohol have a high chance for severe liver
damage.
Types and Examples of Adverse Reactions
Drug Induced liver Injury
• The liver is the main site of metabolism for drugs
and other exogenous compounds.
• vulnerable organ, exposed to parent drug and
metabolite.
• despite this vulnerability, the liver is not the
major target for adverse drug reactions, only
about 9.5% of these involve the liver .
• Overdose of Acetaminophen is a common cause
of hepatic injury, accounting for ~40 % of cases of
acute liver failure in the USA
Types of Drug Induced Hepatoxcity

http://ispub.com/IJPHARM/7/1/3723#
Case Study on Troglitazone (Rezulin)
• Troglitazone(Thiazolidinediones class)

• Class of Oral Antidiabetics for (peroxisome
proliferator-activated receptor gamma)
• Mechanism:Troglitazone lowers blood glucose
levels through increased glucose uptake by
skeletal muscle, decreased hepatic glucose
production. Approved by FDA 1997
Adverse Reaction Study
At Clinical trials , elevations of serum alanine
aminotransferase (ALT) more than three times the
upper limit of normal were observed in 48 out of
2,510 patients (1.9%) treated with troglitazone as
compared to 0.6% in patients who received
placebo. Troglitazone reported to get associated
idiosyncratic hepatotoxicity with some patients
showing severe or fatal liver damage.
Withdrawn from the market in the US and Japan
in March 2000.
Troglitazone Metabolites
phenol sulfotransferase, ST1A3

Glucuronosyltransferase

CYP3A4,CYP2C8

Metabolite 1:Troglitazone sulphate
Metabolite 3:Troglitazone quinone

Metabolite 2: Troglitazone glucuronide
Metabolite 4: Hydroxylated Metabolite 1

Oxidation of troglitazone to a quinone-type metabolite catalyzed by cytochrome P-450 2C8 and P-450 3A4 in human liver
microsomes. Drug Metab Dispos. 1999 Nov;27(11):1260-6.
Websites for Side Effects and Adverse Drug
Reactions
• FDA : FAERS Systeme Data From 2004-2012
• Sider : The SIDER Side Effect Resource represents
an effort to aggregate dispersed public
information on side
effects(http://sideeffects.embl.de/)
• MedEffect Canada: The Canada Vigilance Adverse
Reaction Online Database contains information
about suspected adverse reactions
References
• http://ispub.com/IJPHARM/7/1/3723#
• https://www.med.upenn.edu/gastro/documents/NEJMdrughepatotoxicity
II.pdf
• http://www.fda.gov/downloads/Drugs/ResourcesForYou/Consumers/Buyi
ngUsingMedicineSafely/EnsuringSafeUseofMedicine/GeneralUseofMedici
ne/UCM229033.pdf
• http://www.bmj.com/content/316/7140/1295
• http://www.sciencemag.org/content/321/5886/263
• http://stm.sciencemag.org/content/4/125/125ra31.long

Más contenido relacionado

La actualidad más candente

Drug information final
Drug information finalDrug information final
Drug information finalSitaram Khadka
 
Pharmacokinetics of drug interaction
Pharmacokinetics of drug interactionPharmacokinetics of drug interaction
Pharmacokinetics of drug interactionDr. Ramesh Bhandari
 
Introduction to pharmacovigilance
Introduction to pharmacovigilanceIntroduction to pharmacovigilance
Introduction to pharmacovigilanceNahla Amin
 
Clinical literature evaluation
Clinical literature evaluationClinical literature evaluation
Clinical literature evaluationAhlam Sundus
 
Medication history interview
Medication history interviewMedication history interview
Medication history interviewRafi Bhat
 
Systematic approach in answering DI queries request
Systematic approach in answering   DI queries requestSystematic approach in answering   DI queries request
Systematic approach in answering DI queries requestKhadga Raj
 
Clinical pharmacy services
Clinical pharmacy servicesClinical pharmacy services
Clinical pharmacy servicesRafi Bhat
 
Pharmacovigilance full information
Pharmacovigilance full informationPharmacovigilance full information
Pharmacovigilance full informationRavindra Kumar
 
DRUG UTILIZATION EVALUATION
DRUG UTILIZATION EVALUATIONDRUG UTILIZATION EVALUATION
DRUG UTILIZATION EVALUATIONaishuanju
 
Detection, reporting and management of adverse events
Detection, reporting and management of adverse eventsDetection, reporting and management of adverse events
Detection, reporting and management of adverse eventsKatla Swapna
 
Pharmacovigilance ppt
Pharmacovigilance pptPharmacovigilance ppt
Pharmacovigilance pptPrasad Bhat
 

La actualidad más candente (20)

Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
 
Drug information final
Drug information finalDrug information final
Drug information final
 
Pharmacokinetics of drug interaction
Pharmacokinetics of drug interactionPharmacokinetics of drug interaction
Pharmacokinetics of drug interaction
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
 
Patient counselling
Patient counsellingPatient counselling
Patient counselling
 
Introduction to pharmacovigilance
Introduction to pharmacovigilanceIntroduction to pharmacovigilance
Introduction to pharmacovigilance
 
Clinical literature evaluation
Clinical literature evaluationClinical literature evaluation
Clinical literature evaluation
 
Medication history interview
Medication history interviewMedication history interview
Medication history interview
 
Adverse drug reactions
Adverse drug reactionsAdverse drug reactions
Adverse drug reactions
 
Systematic approach in answering DI queries request
Systematic approach in answering   DI queries requestSystematic approach in answering   DI queries request
Systematic approach in answering DI queries request
 
Adverse drug reaction monitoring
Adverse drug reaction monitoringAdverse drug reaction monitoring
Adverse drug reaction monitoring
 
Clinical pharmacy services
Clinical pharmacy servicesClinical pharmacy services
Clinical pharmacy services
 
Pharmacovigilance full information
Pharmacovigilance full informationPharmacovigilance full information
Pharmacovigilance full information
 
DRUG UTILIZATION EVALUATION
DRUG UTILIZATION EVALUATIONDRUG UTILIZATION EVALUATION
DRUG UTILIZATION EVALUATION
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
 
Detection, reporting and management of adverse events
Detection, reporting and management of adverse eventsDetection, reporting and management of adverse events
Detection, reporting and management of adverse events
 
adverse drug reactions management
adverse drug reactions  managementadverse drug reactions  management
adverse drug reactions management
 
Drug interactions
Drug interactionsDrug interactions
Drug interactions
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
 
Pharmacovigilance ppt
Pharmacovigilance pptPharmacovigilance ppt
Pharmacovigilance ppt
 

Destacado

Adverse drug reaction
Adverse drug reactionAdverse drug reaction
Adverse drug reactionZumar Mushtaq
 
Drug and the hypersensitivity reactions
Drug and the hypersensitivity reactionsDrug and the hypersensitivity reactions
Drug and the hypersensitivity reactionsChimi Handique
 
Adverse Drug Reactions
Adverse Drug ReactionsAdverse Drug Reactions
Adverse Drug ReactionsEneutron
 
Adverse Drug Reactions - Identifying, Causality & Reporting
Adverse Drug Reactions - Identifying, Causality & ReportingAdverse Drug Reactions - Identifying, Causality & Reporting
Adverse Drug Reactions - Identifying, Causality & ReportingRuella D'Costa Fernandes
 
Adverse drug reactions
Adverse drug  reactionsAdverse drug  reactions
Adverse drug reactionssuniu
 
Adverse drug reactions
Adverse drug reactionsAdverse drug reactions
Adverse drug reactionsDr.Vijay Talla
 
Clinical patterns of adverse drug reactions ppt
Clinical patterns of adverse drug reactions pptClinical patterns of adverse drug reactions ppt
Clinical patterns of adverse drug reactions pptDr Daulatram Dhaked
 

Destacado (12)

ADRs (VK)
ADRs (VK)ADRs (VK)
ADRs (VK)
 
Adverse drugeffects
Adverse drugeffectsAdverse drugeffects
Adverse drugeffects
 
Adverse drug reaction
Adverse drug reactionAdverse drug reaction
Adverse drug reaction
 
ADR AND ITS MONITORING
ADR  AND  ITS MONITORING ADR  AND  ITS MONITORING
ADR AND ITS MONITORING
 
Drug and the hypersensitivity reactions
Drug and the hypersensitivity reactionsDrug and the hypersensitivity reactions
Drug and the hypersensitivity reactions
 
Adverse Drug Reactions
Adverse Drug ReactionsAdverse Drug Reactions
Adverse Drug Reactions
 
Adverse Drug Reactions - Identifying, Causality & Reporting
Adverse Drug Reactions - Identifying, Causality & ReportingAdverse Drug Reactions - Identifying, Causality & Reporting
Adverse Drug Reactions - Identifying, Causality & Reporting
 
Adverse drug reactions
Adverse drug  reactionsAdverse drug  reactions
Adverse drug reactions
 
Adverse drug reactions ppt
Adverse drug reactions pptAdverse drug reactions ppt
Adverse drug reactions ppt
 
Adverse Drug Reactions
Adverse Drug ReactionsAdverse Drug Reactions
Adverse Drug Reactions
 
Adverse drug reactions
Adverse drug reactionsAdverse drug reactions
Adverse drug reactions
 
Clinical patterns of adverse drug reactions ppt
Clinical patterns of adverse drug reactions pptClinical patterns of adverse drug reactions ppt
Clinical patterns of adverse drug reactions ppt
 

Similar a Introduction to Adverse Drug Reactions

ADR Class for Nurses.pptx
ADR Class for Nurses.pptxADR Class for Nurses.pptx
ADR Class for Nurses.pptxDr.Irfan shaikh
 
ADVERSE EFFECTS OF DRUGS
ADVERSE EFFECTS OF DRUGSADVERSE EFFECTS OF DRUGS
ADVERSE EFFECTS OF DRUGSSanjogBam
 
Adverse Drug Reaction and Drug Interaction_PHARMACY PRACTICE
Adverse Drug Reaction and Drug Interaction_PHARMACY PRACTICEAdverse Drug Reaction and Drug Interaction_PHARMACY PRACTICE
Adverse Drug Reaction and Drug Interaction_PHARMACY PRACTICErishi2789
 
DJ- ADR - 08.09.2021.pptx
DJ- ADR - 08.09.2021.pptxDJ- ADR - 08.09.2021.pptx
DJ- ADR - 08.09.2021.pptxMuskanAslam
 
ADR by Mukesh Jaiswal & Somya Verma
ADR by Mukesh Jaiswal & Somya VermaADR by Mukesh Jaiswal & Somya Verma
ADR by Mukesh Jaiswal & Somya VermaMukesh Jaiswal
 
Adverse Drug Reactions (ADR) Introduction.pptx
Adverse Drug Reactions (ADR) Introduction.pptxAdverse Drug Reactions (ADR) Introduction.pptx
Adverse Drug Reactions (ADR) Introduction.pptxMrSALAJKHARE
 
Adverse drug reaction for mbbs
Adverse drug reaction for mbbsAdverse drug reaction for mbbs
Adverse drug reaction for mbbsmani goel
 
Adverse Drug reaction ppt
Adverse Drug reaction ppt Adverse Drug reaction ppt
Adverse Drug reaction ppt ShikhaSachde
 
ADR-RDP-2023.pdf
ADR-RDP-2023.pdfADR-RDP-2023.pdf
ADR-RDP-2023.pdfrishi2789
 
Adverse drug reactions
Adverse drug reactionsAdverse drug reactions
Adverse drug reactionsAravinda Kumar
 
Adverse drug reaction and adverse drug event
Adverse drug reaction and adverse drug eventAdverse drug reaction and adverse drug event
Adverse drug reaction and adverse drug eventssuser7add2a
 
Adverse drug reactions
Adverse drug reactions Adverse drug reactions
Adverse drug reactions Faiza Waseem
 

Similar a Introduction to Adverse Drug Reactions (20)

ADR Class for Nurses.pptx
ADR Class for Nurses.pptxADR Class for Nurses.pptx
ADR Class for Nurses.pptx
 
ADVERSE EFFECTS OF DRUGS
ADVERSE EFFECTS OF DRUGSADVERSE EFFECTS OF DRUGS
ADVERSE EFFECTS OF DRUGS
 
Adverse Drug Reaction and Drug Interaction_PHARMACY PRACTICE
Adverse Drug Reaction and Drug Interaction_PHARMACY PRACTICEAdverse Drug Reaction and Drug Interaction_PHARMACY PRACTICE
Adverse Drug Reaction and Drug Interaction_PHARMACY PRACTICE
 
adr-180630071130.pptx
adr-180630071130.pptxadr-180630071130.pptx
adr-180630071130.pptx
 
DJ- ADR - 08.09.2021.pptx
DJ- ADR - 08.09.2021.pptxDJ- ADR - 08.09.2021.pptx
DJ- ADR - 08.09.2021.pptx
 
ADR by Mukesh Jaiswal & Somya Verma
ADR by Mukesh Jaiswal & Somya VermaADR by Mukesh Jaiswal & Somya Verma
ADR by Mukesh Jaiswal & Somya Verma
 
Adverse Drug Reactions
Adverse Drug ReactionsAdverse Drug Reactions
Adverse Drug Reactions
 
Adverse Drug Reactions (ADR) Introduction.pptx
Adverse Drug Reactions (ADR) Introduction.pptxAdverse Drug Reactions (ADR) Introduction.pptx
Adverse Drug Reactions (ADR) Introduction.pptx
 
Adverse drug reactions.pptx
Adverse drug reactions.pptxAdverse drug reactions.pptx
Adverse drug reactions.pptx
 
Adverse drug reaction for mbbs
Adverse drug reaction for mbbsAdverse drug reaction for mbbs
Adverse drug reaction for mbbs
 
Adverse Drug reaction ppt
Adverse Drug reaction ppt Adverse Drug reaction ppt
Adverse Drug reaction ppt
 
ADR.pptx
ADR.pptxADR.pptx
ADR.pptx
 
Adverse Drug Recation.pptx
Adverse Drug Recation.pptxAdverse Drug Recation.pptx
Adverse Drug Recation.pptx
 
ADR-RDP-2023.pdf
ADR-RDP-2023.pdfADR-RDP-2023.pdf
ADR-RDP-2023.pdf
 
Adverse drug reactions
Adverse drug reactionsAdverse drug reactions
Adverse drug reactions
 
Adverse drug reaction and adverse drug event
Adverse drug reaction and adverse drug eventAdverse drug reaction and adverse drug event
Adverse drug reaction and adverse drug event
 
Adverse drug effects
Adverse drug effectsAdverse drug effects
Adverse drug effects
 
Adverse drug reaction
Adverse drug reactionAdverse drug reaction
Adverse drug reaction
 
Adverse drug reactions
Adverse drug reactions Adverse drug reactions
Adverse drug reactions
 
OVERVIEW OF ADR.pptx
OVERVIEW OF ADR.pptxOVERVIEW OF ADR.pptx
OVERVIEW OF ADR.pptx
 

Más de Abhik Seal

Clinicaldataanalysis in r
Clinicaldataanalysis in rClinicaldataanalysis in r
Clinicaldataanalysis in rAbhik Seal
 
Virtual Screening in Drug Discovery
Virtual Screening in Drug DiscoveryVirtual Screening in Drug Discovery
Virtual Screening in Drug DiscoveryAbhik Seal
 
Data manipulation on r
Data manipulation on rData manipulation on r
Data manipulation on rAbhik Seal
 
Data handling in r
Data handling in rData handling in r
Data handling in rAbhik Seal
 
Modeling Chemical Datasets
Modeling Chemical DatasetsModeling Chemical Datasets
Modeling Chemical DatasetsAbhik Seal
 
Mapping protein to function
Mapping protein to functionMapping protein to function
Mapping protein to functionAbhik Seal
 
Sequencedatabases
SequencedatabasesSequencedatabases
SequencedatabasesAbhik Seal
 
Chemical File Formats for storing chemical data
Chemical File Formats for storing chemical dataChemical File Formats for storing chemical data
Chemical File Formats for storing chemical dataAbhik Seal
 
Understanding Smiles
Understanding Smiles Understanding Smiles
Understanding Smiles Abhik Seal
 
Learning chemistry with google
Learning chemistry with googleLearning chemistry with google
Learning chemistry with googleAbhik Seal
 
3 d virtual screening of pknb inhibitors using data
3 d virtual screening of pknb inhibitors using data3 d virtual screening of pknb inhibitors using data
3 d virtual screening of pknb inhibitors using dataAbhik Seal
 
R scatter plots
R scatter plotsR scatter plots
R scatter plotsAbhik Seal
 
Q plot tutorial
Q plot tutorialQ plot tutorial
Q plot tutorialAbhik Seal
 
Pharmacohoreppt
PharmacohorepptPharmacohoreppt
PharmacohorepptAbhik Seal
 

Más de Abhik Seal (20)

Chemical data
Chemical dataChemical data
Chemical data
 
Clinicaldataanalysis in r
Clinicaldataanalysis in rClinicaldataanalysis in r
Clinicaldataanalysis in r
 
Virtual Screening in Drug Discovery
Virtual Screening in Drug DiscoveryVirtual Screening in Drug Discovery
Virtual Screening in Drug Discovery
 
Data manipulation on r
Data manipulation on rData manipulation on r
Data manipulation on r
 
Data handling in r
Data handling in rData handling in r
Data handling in r
 
Networks
NetworksNetworks
Networks
 
Modeling Chemical Datasets
Modeling Chemical DatasetsModeling Chemical Datasets
Modeling Chemical Datasets
 
Mapping protein to function
Mapping protein to functionMapping protein to function
Mapping protein to function
 
Sequencedatabases
SequencedatabasesSequencedatabases
Sequencedatabases
 
Chemical File Formats for storing chemical data
Chemical File Formats for storing chemical dataChemical File Formats for storing chemical data
Chemical File Formats for storing chemical data
 
Understanding Smiles
Understanding Smiles Understanding Smiles
Understanding Smiles
 
Learning chemistry with google
Learning chemistry with googleLearning chemistry with google
Learning chemistry with google
 
3 d virtual screening of pknb inhibitors using data
3 d virtual screening of pknb inhibitors using data3 d virtual screening of pknb inhibitors using data
3 d virtual screening of pknb inhibitors using data
 
Poster
PosterPoster
Poster
 
R scatter plots
R scatter plotsR scatter plots
R scatter plots
 
Indo us 2012
Indo us 2012Indo us 2012
Indo us 2012
 
Q plot tutorial
Q plot tutorialQ plot tutorial
Q plot tutorial
 
Weka guide
Weka guideWeka guide
Weka guide
 
Pharmacohoreppt
PharmacohorepptPharmacohoreppt
Pharmacohoreppt
 
Document1
Document1Document1
Document1
 

Último

Jamworks pilot and AI at Jisc (20/03/2024)
Jamworks pilot and AI at Jisc (20/03/2024)Jamworks pilot and AI at Jisc (20/03/2024)
Jamworks pilot and AI at Jisc (20/03/2024)Jisc
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxRamakrishna Reddy Bijjam
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxVishalSingh1417
 
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptxHMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptxmarlenawright1
 
Wellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptxWellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptxJisc
 
How to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptxHow to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptxCeline George
 
SOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning PresentationSOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning Presentationcamerronhm
 
Fostering Friendships - Enhancing Social Bonds in the Classroom
Fostering Friendships - Enhancing Social Bonds  in the ClassroomFostering Friendships - Enhancing Social Bonds  in the Classroom
Fostering Friendships - Enhancing Social Bonds in the ClassroomPooky Knightsmith
 
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...Pooja Bhuva
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfPoh-Sun Goh
 
Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Jisc
 
How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17Celine George
 
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfUGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfNirmal Dwivedi
 
FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024Elizabeth Walsh
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfagholdier
 
Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...Association for Project Management
 
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdf
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdfUnit 3 Emotional Intelligence and Spiritual Intelligence.pdf
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdfDr Vijay Vishwakarma
 
Interdisciplinary_Insights_Data_Collection_Methods.pptx
Interdisciplinary_Insights_Data_Collection_Methods.pptxInterdisciplinary_Insights_Data_Collection_Methods.pptx
Interdisciplinary_Insights_Data_Collection_Methods.pptxPooja Bhuva
 
Towards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptxTowards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptxJisc
 

Último (20)

Jamworks pilot and AI at Jisc (20/03/2024)
Jamworks pilot and AI at Jisc (20/03/2024)Jamworks pilot and AI at Jisc (20/03/2024)
Jamworks pilot and AI at Jisc (20/03/2024)
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptxHMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
 
Wellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptxWellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptx
 
How to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptxHow to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptx
 
SOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning PresentationSOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning Presentation
 
Fostering Friendships - Enhancing Social Bonds in the Classroom
Fostering Friendships - Enhancing Social Bonds  in the ClassroomFostering Friendships - Enhancing Social Bonds  in the Classroom
Fostering Friendships - Enhancing Social Bonds in the Classroom
 
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdf
 
Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17
 
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfUGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
 
FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...
 
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdf
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdfUnit 3 Emotional Intelligence and Spiritual Intelligence.pdf
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdf
 
Interdisciplinary_Insights_Data_Collection_Methods.pptx
Interdisciplinary_Insights_Data_Collection_Methods.pptxInterdisciplinary_Insights_Data_Collection_Methods.pptx
Interdisciplinary_Insights_Data_Collection_Methods.pptx
 
Towards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptxTowards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptx
 

Introduction to Adverse Drug Reactions

  • 2. What is ADR WHO definition : Any undesirable effect of a drug beyond its anticipated therapeutic effects occurring during clinical use An adverse drug reaction (ADR) is an expression that describes harm associated with the use of given medications at a normal dosage during normal use. - ADRs may occur following a single dose or prolonged administration of a drug or result from the combination of two or more drugs The meaning of this expression differs from the meaning of "side effect", as it might also imply that the effects can be beneficial.
  • 3. Why ADR is Important to know • Over 2 Million serious ADRs yearly. • 100,000 deaths yearly. • ADRs 4th leading cause of death ahead of pulmonary disease, diabetes, AIDS, pneumonia, accidents and automobile deaths. • Ambulatory patients ADR rate—unknown • Nursing home patients ADR rate— 350,000 yearly. Institute of Medicine, National Academy Press, 2000 Lazarou J et al. JAMA 1998;279(15):1200–1205 Gurwitz JH et al. Am J Med 2000;109(2):87–94
  • 4. Classification of adverse drug reaction ABCDE Classification Rawlins and Thompson devised a classification scheme in 1991, which continues to be the most frequently used. • Type A: Predictable, acute, related to mechanism of action • Type B: Idiosyncratic, unpredictable, acute / sub-acute, not related to known mechanism • Type C: Chronic effects (continuous) • Type D: Delayed effects • Type E: End-of-treatment effects
  • 5. Classification of adverse drug reaction Type A • Dose Related • 80% of ADR, usually a consequence of the drug’s primary pharmacological effect (e.g. bleeding from warfarin, Headache with glyceryltrinitrate (GTN)) • a low therapeutic index (e.g. nausea from digoxin)
  • 6. Classification of adverse drug reaction Type B • Bizarre effects (or idiosyncratic) • dose independent and • Unpredictable (not an extension pharmacological action of the drug) • For example: hepatotoxicity due to paracetamol tinnitus induced by aspirin ototoxicity with aminoglycosides of main
  • 7. Classification of adverse drug reaction • Type A less likely to have fatal consequences than type B reactions Type Type A Type B Dose Relationship Yes No Frequency Common Rarer Mortality Low Higher Morbidity High Lower Treatment Stop drug or reduce dose Stop drug
  • 8. Classification of adverse drug reaction Type C • Results from Chronic or continuous use • For example, Analgesic nephropathy • osteoporosis during continued high-dose glucocorticoid therapy • tardive dyskinesia during continuous use of antipsychotic drugs
  • 9. Classification of adverse drug reaction Type D These reactions refer to carcinogenic and teratogenic effects. These reactions are delayed in onset and are very rare since extensive mutagenicity and carcinogenicity studies are done before drug is licensed. • • • • • • • • Teratogenic Thalidomide - amelia or micromelia or phocomelia phenytoin -fetal hydantoin syndrome tetracyclines -teeth malformation and discoloration aspirin -early closure of ductus arteriosus carbamazepine -cleft lip and palate, microcephaly wafarin - saddle nose sodium valproate - spina bifida DES - vaginal clear cell adenocarcinoma
  • 10. Classification of adverse drug reaction Type E • Rebound adrenal insufficiency • Withdrawal syndrome (tachycardia on abrupt discontinuation of β-adrenoceptor blockade) • Second malignancies following successful chemotherapy.
  • 11. Physiological, Pharmacological and Toxicological aspects of metabolism of Drugs
  • 12. Drug- Drug Interactions Pharmacokinetic and pharmacodynamic properties of one drug affect either the pharmacokinetics or pharmacodynamics of another drug Pharmacokinetics:“What the body does to the drug” Pharmacodynamics:“What the drug does to the body”
  • 13. Types of Drug Drug Interactions • Potentiation: Drugs with similar actions cause an additive effect • Coumadin and aspirin taken together cause excessive bleeding • Sedatives and alcohol cause excessive sedation
  • 14. Types of Drug Drug Interactions • Interference: One drug accelerates or slows the metabolism or excretion of another drug Erythromycin taken with – Digoxin = elevated blood levels of digoxin – Coumadin = enhanced action of Coumadin Potential for serious adverse effects!
  • 15. Types of Drug Drug Interactions • Displacement: Two drugs compete for protein binding sites – One drug “wins” (is bound to protein) – Displaced drug is active in greater quantities – Same effect as taking a higher dose of the displaced drug! A major cause of drug-drug interactions!
  • 16. Types of Drug Drug Interactions • Antagonism: One drug decreases the effectiveness of another drug because of divergent actions – Oral ketoconazole (Nizoral) is absorbed in an acidic environment – H2-receptor antagonists or proton pump inhibitors decrease acidity in the stomach – Differing action decreases Nizoral effectiveness
  • 17. Types of Drug Drug Interactions • CYP450 enzymes and drug-drug interactions – CYP450 Inhibitors: Drug A inhibits CYP450 enzymes in the liver; slows metabolism of drug B, toxic levels of drug B accumulate – CYP450 Inducers: Drug A stimulates production of CYP450 enzymes; increases rate of metabolism of drug B, clears drug B out of the system faster A major source of drug-drug interactions!
  • 18. Drug Food Interactions • Food can alter the absorption or metabolism of medications • Diets can alter the bacterial flora of the intestine and may affect the metabolism of certain drugs • Iron taken with acidic foods can cause increased iron absorption • Acetaminophen or Aspirin taken with or after alcohol have a high chance for severe liver damage.
  • 19. Types and Examples of Adverse Reactions
  • 20. Drug Induced liver Injury • The liver is the main site of metabolism for drugs and other exogenous compounds. • vulnerable organ, exposed to parent drug and metabolite. • despite this vulnerability, the liver is not the major target for adverse drug reactions, only about 9.5% of these involve the liver . • Overdose of Acetaminophen is a common cause of hepatic injury, accounting for ~40 % of cases of acute liver failure in the USA
  • 21. Types of Drug Induced Hepatoxcity http://ispub.com/IJPHARM/7/1/3723#
  • 22. Case Study on Troglitazone (Rezulin) • Troglitazone(Thiazolidinediones class) • Class of Oral Antidiabetics for (peroxisome proliferator-activated receptor gamma) • Mechanism:Troglitazone lowers blood glucose levels through increased glucose uptake by skeletal muscle, decreased hepatic glucose production. Approved by FDA 1997
  • 23. Adverse Reaction Study At Clinical trials , elevations of serum alanine aminotransferase (ALT) more than three times the upper limit of normal were observed in 48 out of 2,510 patients (1.9%) treated with troglitazone as compared to 0.6% in patients who received placebo. Troglitazone reported to get associated idiosyncratic hepatotoxicity with some patients showing severe or fatal liver damage. Withdrawn from the market in the US and Japan in March 2000.
  • 24. Troglitazone Metabolites phenol sulfotransferase, ST1A3 Glucuronosyltransferase CYP3A4,CYP2C8 Metabolite 1:Troglitazone sulphate Metabolite 3:Troglitazone quinone Metabolite 2: Troglitazone glucuronide Metabolite 4: Hydroxylated Metabolite 1 Oxidation of troglitazone to a quinone-type metabolite catalyzed by cytochrome P-450 2C8 and P-450 3A4 in human liver microsomes. Drug Metab Dispos. 1999 Nov;27(11):1260-6.
  • 25. Websites for Side Effects and Adverse Drug Reactions • FDA : FAERS Systeme Data From 2004-2012 • Sider : The SIDER Side Effect Resource represents an effort to aggregate dispersed public information on side effects(http://sideeffects.embl.de/) • MedEffect Canada: The Canada Vigilance Adverse Reaction Online Database contains information about suspected adverse reactions
  • 26. References • http://ispub.com/IJPHARM/7/1/3723# • https://www.med.upenn.edu/gastro/documents/NEJMdrughepatotoxicity II.pdf • http://www.fda.gov/downloads/Drugs/ResourcesForYou/Consumers/Buyi ngUsingMedicineSafely/EnsuringSafeUseofMedicine/GeneralUseofMedici ne/UCM229033.pdf • http://www.bmj.com/content/316/7140/1295 • http://www.sciencemag.org/content/321/5886/263 • http://stm.sciencemag.org/content/4/125/125ra31.long